This study aimed to isolate
Streptomyces
sp. from Moroccan terrestrial ecosystems and identify bioactive compounds through GC–MS analysis. Antimicrobial activity was assessed against various pathogenic microorganisms including
Staphylococcus aureus
ATCC 25923,
Pseudomonas aeruginosa
ATCC 27853,
Escherichia coli
ATCC 25922 and
Candida albicans
ATCC 60193, and multi-drug resistant strains comprising
Listeria monocytogenes
,
Klebsiella pneumoniae
19K 929,
Proteus
sp. 19K1313,
Klebsiella pneumoniae
20B1572,
Proteus vulgaris
16C1737, and
Klebsiella pneumoniae
20B1572. Based on the results of the gene sequencing of gene 16S rRNA and phylogenetic analysis, the E2 isolate belongs to the genus
Streptomyces
with the highest degree of resemblance (97.51%) to the
Streptomyces africanus strain
NBRC 101005 (NR_112600.1). The isolate exhibited broad-spectrum antibacterial activity, with maximum efficacy against
Klebsiella pneumoniae
20B1572 indicated by an inhibition zone diameter of 22.5 ± 0.71mm and a minimum inhibitory concentration (MIC) of 0.0625 mg/mL. The in vitro antioxidant potential of E2 strain was determined through screening of its ethyl acetate extract against sets of antioxidant assays. The results were indicative of E2 strain displaying strong antioxidant activity against ABTS, DPPH free radicals, and FRAP. Furthermore, there was a high significant correlation (p < 0.0001) between the total phenolic and flavonoid content and antioxidant activities. The GC–MS analysis of the extract identified six volatile compounds, with Eugenol (96%) and Maltol (93%) being the most prominent. Additionally, the HPLC–UV/vis analysis revealed six phenolic compounds: gallic acid, chlorogenic acid, vanillic acid, trans-ferulic acid, ellagic acid, and cinnamic acid. Overall, the study highlights
Streptomyces
sp. strain E2 as a potential source of potent antimicrobial and antioxidant metabolites, offering promise in addressing antibiotic resistance and oxidative stress-related conditions.